🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer

Recruitingn/aAges 18 Years - 85 YearsAllFondazione Policlinico Universitario Agostino Gem…
NCT05950503 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age \> 18 years; * Histological diagnosis of colorectal cancer; * Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG); * At least one measurable liver lesion according to RECIST 1.1 criteria; * Adequate organ and marrow function. Exclusion Criteria: * Age \< 18 years; * Inability to undergo MRI; * Major contraindications to liver surgery; * No written informed consent.
💊

What it tests

  • Hepatic MRI
📍

Where

1 site
Policlinico Agostino Gemelli
Roma, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy